文献速递肝胆胰外科围术期管理与 ERAS

开放、腹腔镜与机器人远端胰腺切除术经济效率评估:更新的系统评价与网状Meta分析

Evaluating the economic efficiency of open, laparoscopic, and robotic distal pancreatectomy: an updated systematic review and network meta-analysis.
PubMed 文献 · Surg Endosc · 2024-05-22

该系统评价与网状Meta分析纳入26项研究共29164例患者,比较开放(ODP)、腹腔镜(LDP)与机器人(RDP)远端胰腺切除术的成本效果。LDP总体成本最低,ODP最高;RDP手术成本最高但住院成本最低。LDP和RDP较ODP更具成本效果。

要点

  • LDP总体成本最低,ODP总体成本最高(LDP vs ODP:MD -3521.36,95% CrI -6172.91至-1228.59)。
  • RDP手术成本最高,但住院成本最低;LDP和RDP住院成本均显著低于ODP。
  • 与ODP相比,LDP和RDP每例患者分别节省3110美元和817美元,并分别增加0.03和0.05个质量调整生命年(QALY)。

核心结论

  • LDP和RDP较ODP更具成本效果,LDP成本节约更优,RDP手术结局和QALY改善更优。

研究设计与样本

  • 系统评价与网状Meta分析,检索截至2023年8月的文献,纳入报告远端胰腺切除术成本的研究,共26项研究29164例患者;采用贝叶斯网状Meta分析计算SUCRA值、MD、OR及95% CrI,并进行聚类分析和基于决策模型的质量调整生命年成本效用分析。

主要发现

  • LDP总体成本最低,ODP总体成本最高(LDP vs ODP:MD -3521.36,95% CrI -6172.91至-1228.59)。
  • RDP手术成本最高(ODP vs RDP:MD -4311.15,95% CrI -6005.40至-2599.16;LDP vs RDP:MD -3772.25,95% CrI -4989.50至-2535.16),但住院成本最低。
  • LDP(MD -3663.82,95% CrI -6906.52至-747.69)和RDP(MD -6678.42,95% CrI -11434.30至-2972.89)住院成本较ODP显著降低。
  • 与ODP相比,LDP和RDP每例患者分别节省3110美元和817美元,分别增加0.03和0.05个QALY,增量净货币效益(NMB)为正。
  • RDP较LDP每例患者多花费2293美元,增量NMB为负,但增加0.02个QALY,并改善术后并发症和脾保留。

关键数值与推荐

  • LDP与ODP总体成本MD -3521.36(95% CrI -6172.91至-1228.59)。
  • ODP与RDP手术成本MD -4311.15(95% CrI -6005.40至-2599.16);LDP与RDP手术成本MD -3772.25(95% CrI -4989.50至-2535.16)。
  • LDP与ODP住院成本MD -3663.82(95% CrI -6906.52至-747.69);RDP与ODP住院成本MD -6678.42(95% CrI -11434.30至-2972.89)。
  • 与ODP相比,LDP和RDP每例患者分别节省3110美元和817美元,分别增加0.03和0.05个QALY,增量NMB为正;RDP较LDP多花费2293美元,增量NMB为负,增加0.02个QALY。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study compared the cost-effectiveness of open (ODP), laparoscopic (LDP), and robotic (RDP) distal pancreatectomy (DP). METHODS: Studies reporting the costs of DP were included in a literature search until August 2023. Bayesian network meta-analysis was conducted, and surface under cumulative ranking area (SUCRA) values, mean difference (MD), odds ratio (OR), and 95% credible intervals (CrIs) were calculated for outcomes of interest. Cluster analysis was performed to examine the similarity and classification of DP approaches into homogeneous clusters. A decision model-based cost-utility analysis was conducted for the cost-effectiveness analysis of DP strategies. RESULTS: Twenty-six studies with 29,164 patients were included in the analysis. Among the three groups, LDP had the lowest overall costs, while ODP had the highest overall costs (LDP vs. ODP: MD - 3521.36, 95% CrI - 6172.91 to - 1228.59). RDP had the highest procedural costs (ODP vs. RDP: MD - 4311.15, 95% CrI - 6005.40 to - 2599.16; LDP vs. RDP: MD - 3772.25, 95% CrI - 4989.50 to - 2535.16), but incurred the lowest hospitalization costs. Both LDP (MD - 3663.82, 95% CrI - 6906.52 to - 747.69) and RDP (MD - 6678.42, 95% CrI - 11,434.30 to - 2972.89) had significantly reduced hospitalization costs compared to ODP. LDP and RDP demonstrated a superior profile regarding costs-morbidity, costs-mortality, costs-efficacy, and costs-utility compared to ODP. Compared to ODP, LDP and RDP cost $3110 and $817 less per patient, resulting in 0.03 and 0.05 additional quality-adjusted life years (QALYs), respectively, with positive incremental net monetary benefit (NMB). RDP costs $2293 more than LDP with a negative incremental NMB but generates 0.02 additional QALYs with improved postoperative morbidity and spleen preservation. Probabilistic sensitivity analysis suggests that LDP and RDP are more cost-effective options compared to ODP at various willingness-to-pay thresholds. CONCLUSION: LDP and RDP are more cost-effective than ODP, with LDP exhibiting better cost savings and RDP demonstrating superior surgical outcomes and improved QALYs.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Koh YX, Zhao Y, Tan IE, et al. Evaluating the economic efficiency of open, laparoscopic, and robotic distal pancreatectomy: an updated systematic review and network meta-analysis. Surg Endosc. 2024. PMID: 38777892. doi:10.1007/s00464-024-10889-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。